After Intuitive Surgical (ISRG) announced this morning that President Dave Rosa will be promoted to Chief Executive Officer, Baird said the firm believes Rosa has long been slated to take over the CEO role, given his 29-plus years at the company. The firm, which expects Rosa to be “well-equipped to continue to further ISRG’s position as a best-in-class MedTech growth story,” keeps an Outperform and $575 price target on Intuitive Surgical shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical Appoints David Rosa as CEO
- Intuitive Surgical announces promotion of Dave Rosa to CEO
- Wolfpack Research says short UFP Technologies, growth story ‘in shambles’
- Intuitive Surgical Expands Stock Repurchase Program to $4B
- Intuitive Surgical announces FDA clearance of da Vinci Single Port system